Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


Articles published in Histopathology

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    April 2024
  1. LI JJX, Ni SYB, Tsang JYS, Chan WY, et al
    Neutrophil-lymphocyte ratio reflects tumour-infiltrating lymphocytes and tumour-associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapy.
    Histopathology. 2024;84:810-821.
    PubMed     Abstract available


  2. ALKHAYYAT R, Abbas A, Quinn CM, Rakha EA, et al
    Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls.
    Histopathology. 2024;84:723-741.
    PubMed     Abstract available


  3. AZAM AS, Tsang YW, Thirlwall J, Kimani PK, et al
    Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite study.
    Histopathology. 2024;84:847-862.
    PubMed     Abstract available


    March 2024
  4. LY A, Garcia V, Blenman KRM, Ehinger A, et al
    Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research.
    Histopathology. 2024 Mar 3. doi: 10.1111/his.15140.
    PubMed     Abstract available


    January 2024
  5. LUI JW, Tsang JY, Li J, Ko CW, et al
    TRPS1 is a promising marker for all subtypes of breast cancer.
    Histopathology. 2024 Jan 3. doi: 10.1111/his.15126.
    PubMed     Abstract available


  6. SCHWARTZ CJ, Krings G, Chen YY
    Malignant phyllodes tumour with lymph node metastasis: a diagnostic conundrum resolved by next generation DNA sequencing.
    Histopathology. 2024;84:409-411.
    PubMed     Abstract available


    December 2023
  7. TAN PH, Mihir G, Laokulrath N, Rakha E, et al
    Practical approach to scoring HER2 immunohistochemistry in breast cancer in the wake of updated guidelines.
    Histopathology. 2023 Dec 12. doi: 10.1111/his.15117.
    PubMed    


  8. BOYRAZ B, Sgroi DC, Iafrate AJ, Lerwill MF, et al
    Atypical cystic hypersecretory lesions of the breast commonly harbour TP53 alterations.
    Histopathology. 2023;83:989-993.
    PubMed     Abstract available


    September 2023
  9. LEE AHS, Toss MS, James JJ, Hodi Z, et al
    Preoperative diagnosis of ductal carcinoma in situ of the breast over a 24-year period.
    Histopathology. 2023;83:435-442.
    PubMed     Abstract available


  10. RAKHA EA, Adebayo LA, Abbas A, Hodi Z, et al
    Second opinion (external specialist referral) practice of breast pathology: the Nottingham experience.
    Histopathology. 2023;83:394-405.
    PubMed     Abstract available


  11. GHANNAM SF, Rutland CS, Allegrucci C, Mongan NP, et al
    Encapsulated papillary carcinoma of the breast: does it have a native basement membrane?
    Histopathology. 2023;83:376-393.
    PubMed     Abstract available


  12. AIYER KTS, Kroon LJ, van Leenders GJLH
    Impact of comedonecrosis on prostate cancer outcome: a systematic review.
    Histopathology. 2023;83:339-347.
    PubMed     Abstract available


  13. JORNS JM, Farooq A, Puzyrenko A, Jarzembowski J, et al
    Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)-like change: clinicopathological and molecular characteristics.
    Histopathology. 2023;83:357-365.
    PubMed     Abstract available


    August 2023
  14. NIELSEN TO, Leung SCY, Riaz N, Mulligan AM, et al
    Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial.
    Histopathology. 2023 Aug 23. doi: 10.1111/his.15032.
    PubMed     Abstract available


  15. LEWIS G, Fong N, Gjeorgjievski SG, Li XB, et al
    Low-grade adenosquamous carcinoma of the breast: a clinical, morphological and immunohistochemical analysis of 25 patients.
    Histopathology. 2023;83:252-263.
    PubMed     Abstract available


    July 2023
  16. THORNE H, Devereux L, Li J, Alsop K, et al
    BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme.
    Histopathology. 2023;83:91-103.
    PubMed     Abstract available


    June 2023
  17. GOUGH M, Liu C, Srinivasan B, Wilkinson L, et al
    Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer.
    Histopathology. 2023 Jun 27. doi: 10.1111/his.15000.
    PubMed     Abstract available


    May 2023
  18. HARTER D, O'Connor SM, Hertel JD, Calhoun BC, et al
    Pathological measurement and staging of residual breast cancer after neoadjuvant chemotherapy.
    Histopathology. 2023 May 31. doi: 10.1111/his.14966.
    PubMed     Abstract available


  19. LASHEN AG, Toss MS, Wootton L, Green AR, et al
    Characteristics and prognostic significance of polo-like kinase-1 (PLK1) expression in breast cancer.
    Histopathology. 2023 May 24. doi: 10.1111/his.14960.
    PubMed     Abstract available


    April 2023
  20. ZENG L, Koh VCY, Chen XY, Tan PH, et al
    Tertiary lymphoid structures in breast ductal carcinoma in situ correlate with adverse pathological parameters.
    Histopathology. 2023;82:779-788.
    PubMed     Abstract available


  21. LASHEN A, Toss MS, Fadhil W, Oni G, et al
    Evaluation oncotype DX((R)) 21-gene recurrence score and clinicopathological parameters: a single institutional experience.
    Histopathology. 2023;82:755-766.
    PubMed     Abstract available


  22. MD NASIR ND, Koh VCY, Cree IA, Ruiz BII, et al
    Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast.
    Histopathology. 2023;82:704-712.
    PubMed     Abstract available


  23. CHARTIER S, Brochard C, Martinat C, Coussy F, et al
    TROP2, androgen receptor, and PD-L1 status in histological subtypes of high-grade metaplastic breast carcinomas.
    Histopathology. 2023;82:664-671.
    PubMed     Abstract available


    February 2023
  24. IBRAHIM A, Toss MS, Atallah NM, Al Saleem M, et al
    Combined proliferation and apoptosis index provides better risk stratification in breast cancer.
    Histopathology. 2023 Feb 13. doi: 10.1111/his.14887.
    PubMed     Abstract available


  25. SODE M, Thagaard J, Eriksen JO, Laenkholm AV, et al
    Digital image analysis and assisted reading of the HER2 score display reduced concordance - Pitfalls in the categorization of HER2-low breast cancer.
    Histopathology. 2023 Feb 3. doi: 10.1111/his.14877.
    PubMed     Abstract available


  26. LAI BS, Tsang JY, Li JJ, Poon IK, et al
    Anatomical site and size of sentinel lymph node metastasis predicted additional axillary tumour burden and breast cancer survival.
    Histopathology. 2023 Feb 1. doi: 10.1111/his.14875.
    PubMed     Abstract available


    January 2023
  27. ELLIS IO, Rakha EA, Tse GM, Tan PH, et al
    An international unified approach to reporting and grading invasive breast cancer. An overview of the International Collaboration on Cancer Reporting (ICCR) initiative.
    Histopathology. 2023;82:189-197.
    PubMed     Abstract available


  28. RAKHA EA, Tse GM, Quinn CM
    An update on the pathological classification of breast cancer.
    Histopathology. 2023;82:5-16.
    PubMed     Abstract available


  29. CHAN RC, To CKC, Cheng KCT, Yoshikazu T, et al
    Artificial intelligence in breast cancer histopathology.
    Histopathology. 2023;82:198-210.
    PubMed     Abstract available


  30. PROVENZANO E, Shaaban AM
    Pathology of neoadjuvant therapy and immunotherapy testing for breast cancer.
    Histopathology. 2023;82:170-188.
    PubMed     Abstract available


  31. SOKOLOVA A, Johnstone KJ, McCart Reed AE, Simpson PT, et al
    Hereditary breast cancer: syndromes, tumour pathology and molecular testing.
    Histopathology. 2023;82:70-82.
    PubMed     Abstract available


  32. NOURIEH M, Vibert R, Saint-Ghislain M, Cyrta J, et al
    Next-generation sequencing in breast pathology: real impact on routine practice over a decade since its introduction.
    Histopathology. 2023;82:162-169.
    PubMed     Abstract available


  33. TAN BY, Fox SB, Lakhani SR, Tan PH, et al
    Survey of recurrent diagnostic challenges in breast phyllodes tumours.
    Histopathology. 2023;82:95-105.
    PubMed     Abstract available


  34. TSANG JY, Tse GM
    Update on triple-negative breast cancers - highlighting subtyping update and treatment implication.
    Histopathology. 2023;82:17-35.
    PubMed     Abstract available


  35. LI JJX, Tse GM
    Marker assessments in ER-positive breast cancers: old markers, new applications?
    Histopathology. 2023;82:218-231.
    PubMed     Abstract available


    November 2022
  36. IBRAHIM A, Toss MS, Makhlouf S, Miligy IM, et al
    Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.
    Histopathology. 2022 Nov 8. doi: 10.1111/his.14837.
    PubMed     Abstract available


  37. XU B, Viswanathan K, Umrau K, Al-Ameri TAD, et al
    Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors.
    Histopathology. 2022;81:670-679.
    PubMed     Abstract available


    October 2022
  38. FOX SB, Webster F, Chen CJ, Chua B, et al
    Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low-grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR).
    Histopathology. 2022;81:467-476.
    PubMed     Abstract available


    September 2022
  39. VERNEMMEN AIP, Li X, Roemen GMJM, Speel EM, et al
    Cutaneous metastases of internal malignancies: a single-institution experience.
    Histopathology. 2022;81:329-341.
    PubMed     Abstract available


    August 2022
  40. ATALLAH NM, Toss MS, Green AR, Mongan NP, et al
    Refining the definition of HER2 low class in invasive breast cancer.
    Histopathology. 2022 Aug 28. doi: 10.1111/his.14780.
    PubMed     Abstract available


  41. LASHEN A, Toss MS, Green AR, Mongan NP, et al
    Ki67 assessment in invasive luminal breast cancer: A comparative study between different scoring methods.
    Histopathology. 2022 Aug 23. doi: 10.1111/his.14781.
    PubMed     Abstract available


  42. OISHI N, Feldman AL
    CA9 expression in breast implant-associated anaplastic large cell lymphoma presenting in a lymph node.
    Histopathology. 2022;81:270-272.
    PubMed    


    July 2022
  43. KATAYAMA A, Starczynski J, Toss MS, Shaaban AM, et al
    The frequency and clinical significance of centromere enumeration probe 17 alterations in HER2 immunohistochemistry-equivocal invasive breast cancer.
    Histopathology. 2022 Jul 25. doi: 10.1111/his.14728.
    PubMed     Abstract available


  44. RAKHA E, Tan PH
    Head to head: do neuroendocrine tumours in the breast truly exist?
    Histopathology. 2022;81:2-14.
    PubMed     Abstract available


    February 2022
  45. KATAYAMA A, Toss MS, Parkin M, Sano T, et al
    Nuclear morphology in breast lesions: refining its assessment to improve diagnostic concordance.
    Histopathology. 2022;80:515-528.
    PubMed     Abstract available


  46. ABRAHAO-MACHADO LF, Bacchi CE, de Freitas CP, Hornick JL, et al
    Malignant peripheral nerve sheath tumour with multilineage divergent differentiation including a neuroblastic component.
    Histopathology. 2022;80:607-609.
    PubMed    


    January 2022
  47. KHOURY T, Quinn M, Tian W, Yan L, et al
    Touching tumour-infiltrating lymphocytes in low-risk ductal carcinoma in situ (DCIS) correlate with upgrading to high-grade DCIS.
    Histopathology. 2022;80:291-303.
    PubMed     Abstract available


    December 2021
  48. LI J, Mi W, Guo Y, Ren X, et al
    Artificial intelligence for histological subtype classification of breast cancer: combining multi-scale feature maps and recurrent attention model.
    Histopathology. 2021 Dec 24. doi: 10.1111/his.14613.
    PubMed     Abstract available


  49. MA S, Zhao D, Liu Y, Rohr J, et al
    Some pleomorphic adenomas of the breast share PLAG1 rearrangements with the analogous tumour of the salivary glands.
    Histopathology. 2021;79:1030-1039.
    PubMed     Abstract available


    November 2021
  50. KLARIC KA, Riaz N, Asleh K, Wang XQ, et al
    SOX10 is a highly specific biomarker of basal-like breast cancer.
    Histopathology. 2021 Nov 1. doi: 10.1111/his.14592.
    PubMed     Abstract available


    October 2021
  51. RAKHA E, Mihai R, Abbas A, Bennett R, et al
    Diagnostic concordance of phyllodes tumour of the breast.
    Histopathology. 2021;79:607-618.
    PubMed     Abstract available


  52. CAI L, Yan K, Bu H, Yue M, et al
    Improving Ki67 assessment concordance by the use of an artificial intelligence-empowered microscope: a multi-institutional ring study.
    Histopathology. 2021;79:544-555.
    PubMed     Abstract available


  53. RAKHA E, Tan PH, Ellis I, Quinn C, et al
    Adenomyoepithelioma of the breast: a proposal for classification.
    Histopathology. 2021;79:465-479.
    PubMed     Abstract available


    August 2021
  54. MANSY M, Wotherspoon AC, El-Sharkawi D, Cunningham D, et al
    Fibrin-associated diffuse large B-cell lymphoma misdiagnosed as breast implant-associated anaplastic large-cell lymphoma.
    Histopathology. 2021;79:269-271.
    PubMed    


  55. BODEN ACS, Molin J, Garvin S, West RA, et al
    The human-in-the-loop: an evaluation of pathologists' interaction with artificial intelligence in clinical practice.
    Histopathology. 2021;79:210-218.
    PubMed     Abstract available


    May 2021
  56. MIHAI R, Callagy G, Qassid OL, Loughlin MO, et al
    Correlations of morphological features and surgical management with clinical outcome in a multicentre study of 241 phyllodes tumours of the breast.
    Histopathology. 2021;78:871-881.
    PubMed     Abstract available


    April 2021
  57. RAKHA EA, Quinn CM, Foschini MP, Munoz Martin M, et al
    Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management.
    Histopathology. 2021;78:759-771.
    PubMed     Abstract available


    March 2021
  58. NOSKE A, Ammann JU, Wagner DC, Denkert C, et al
    A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer.
    Histopathology. 2021;78:567-577.
    PubMed     Abstract available


  59. GHOSSEIN CA, Khimraj A, Dogan S, Xu B, et al
    Metastasis to the thyroid gland: a single-institution 16-year experience.
    Histopathology. 2021;78:508-519.
    PubMed     Abstract available


  60. HODA RS, Bowman AS, Zehir A, Razavi P, et al
    Next-generation assessment of human epidermal growth factor receptor 2 gene (ERBB2) amplification status in invasive breast carcinoma: a focus on Group 4 by use of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 te
    Histopathology. 2021;78:498-507.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.